Sign in
4

Changes in Ownership

Invivyd, Inc. Filed Acc 0001193125-26-057828

Chief Scientific Officer sold 37,581 shares at an average $1.56 ($58,600)

  • Chief Scientific Officer acquired 99,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Allen Robert D. III Chief Scientific Officer 2026-02-15 Option exercise 10b5-1 +99,000 152,068 D
Allen Robert D. III Chief Scientific Officer 2026-02-17 Sale 10b5-1 −18,189 $1.54 $28,004 133,879 D
Allen Robert D. III Chief Scientific Officer 2026-02-18 Sale 10b5-1 −19,392 $1.58 $30,597 114,487 D
Derivatives
Allen Robert D. III Chief Scientific Officer 2026-02-15 Option exercise · Restricted Stock Units 10b5-1 −99,000 102,000 D
Open-market sales · 37,581 sh · avg $1.56 · $58,600
Loading xslF345X05/ownership.xml…